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Abstract
From October 2010 to April 2011, in the Italian Veneto Region, 1403 hospitalized patients were tested for influenza
virus infection by specific real time RT-PCR. Overall, 327 samples were positive for either influenza A (75%) or B
(25%) viruses. Among these positive patients two resulted co-infected by A/H1N1v and B viruses. Even though co-
infection with both influenza A and B viruses appears to be a rare event, it occurs naturally and may play a role in
epidemiology and pathogenicity. In the present study the two co-infected patients were a transplant recipient
immunocompromised adult and a child displaying a severe respiratory illness. The co-infection was confirmed by
inoculation of the nasopharyngeal swabs in MDCK.2 cells, followed by immunofluorescence and real time RT-PCR
assays. Moreover, in the case of the adult patient, the immune system response against both viruses was assayed
by hemoagglutination inhibition test against reference influenza virus strains. Both patients fully recovered from
infection, without significant differences with mono-infected patients.
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The study
The influenza epidemic in the 2010/2011 season has
been characterized in Italy, as in the rest of the world,
by a significant co-circulation of influenza A (mostly
H1N1v) and influenza B viruses [1]. 1403 nasopharyn-
geal swabs from hospitalized patients displaying influ-
enza-like illness underwent virological evaluation at the
Microbiology and Virology Unit of the Padova Hospital,
the Italian Veneto Region reference laboratory for the
diagnosis of influenza and other respiratory diseases. In
particular, the viral RNA was extracted from the speci-
mens (NucliSENS
® easyMAG
®,B i o m e r i e u x ,L y o n ,
France) and a standardized controlled real time Reverse
Transcription Polymerase Chain Reaction (RT-PCR) was
performed [2]. This method allows the detection of
influenza A and B viruses and the analysis of influenza
A specific sub-types. In more details, roughly 70 ng of
RNA extracted from each sample were assayed with 5
different primer and probe sets specific for influenza A,
influenza B, A/H1N1v, A/H3N2 and the housekeeping
gene RNasi-P. Overall 327 (23, 3%) samples were posi-
tive for influenza virus. Among the positive samples 62
were positive for influenza B virus (25%) and 265 for
influenza A virus (75%) with a sharp prevalence of A/
H1N1v (183 samples, 69%) over the A/H3N2 (6 sam-
ples, 2.2%). It has to be mentioned that 28.8% of influ-
enza A virus positive samples could not be sub-typed,
likely due to a low efficiency of the H1N1v specific real
time adopted. A similar observation was reported during
last influenza season by different European laboratories,
adopting this same controlled diagnostic system [1]. The
age distribution shows a prevalence of positive patients
in the > 60 year old category, as expected during and
epidemic season of influenza. Interestingly these data,
that are in line with the results reported by different
laboratories in the northern hemisphere [1], show a sig-
nificant co-circulation of influenza A and influenza B
viruses, with in general higher prevalence of the A types
but with an increase of B type especially between
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of influenza viruses and the screenings of several sam-
ples by molecular methods provide the unique opportu-
nity for the analysis of simultaneous infections in the
human population. Indeed such co-infections have not
been widely described and studied so far both because
of a poor interest, before the 2009 pandemics, in the
laboratory confirmation of suspected influenza virus
infections and because of the use of culture-based meth-
ods for diagnosis. In our cohort, A/H1N1v and influenza
B viral genomes were simultaneously detected in two
nasopharyngeal swabs. The viral co-infections were con-
firmed for both patients by viral isolation in MDCK.2
cells. Specifically the two clinical samples were inocu-
lated in shell vials and influenza A and B immunofluor-
escence assay (IFA) was performed 24 h post-infection.
In addition, a real time RT-PCR assay was performed on
culture supernatants (Table 1).
The first case of dual infection was identified in a kid-
ney transplant recipient adult patient (54 years old),
who was not covered by specific vaccination. At the
time of virological diagnosis (11
th of February, 2011) he
displayed mild classical influenza-like illness symptoms.
However, due to his state of immunocompromised
patient, oseltamivir treatment was started. Interestingly,
while both viruses were initially detected at similar con-
centration, as displayed by the real time cycle threshold
(Ct) values, clearance of the B virus was achieved earlier
than in the case of influenza A/H1N1v (Table 2). Co-
infection with A/H1N1v and B viruses was also con-
firmed by assaying a patient serum sample collected the
20
th of February in an hemoagglutination inhibition (HI)
test, performed against the seasonal influenza virus
reference strains (A/California/7/2009 H1N1v, A/Perth/
16/2009 H3N2 and B/Bangladesh/3333/2007). As
expected in an immunocompromised individual, the
obtained HI titers were low, 32 and 16 for the virus A/
California/7/2009 H1N1v and B/Bangladesh/3333/2007,
respectively. No HI titre was detectable in the case of
the A/Perth/16/2009 H3N2 virus, employed as specifi-
city control. Taking into account that this patient, as
mentioned above, was no covered by influenza
vaccination the measured serologic response may be
considered a further confirmation of the dual-infection.
A second case of co-infection by influenza A/H1N1v
and B viruses was found in a 6 month old child, display-
ing severe respiratory symptoms and pneumonia. The
15
th of February the child had undertaken antibiotic
treatment by intravenous and nebulised routes. The 18
th
of February the real time RT-PCR assay showed the pre-
sence of both influenza virus type B and A, with levels
of influenza B virus roughly 10 times higher (Ct 30, 76)
with respect to the ones displayed by the A/H1N1v
virus (Ct 32, 86). The child did not underwent antiviral
treatment, the clinical symptoms and signs resolved
quickly and the 22
nd of February he was discharged
without further virological analysis.
Discussion
Dual infections of influenza A and B viruses appear to
be a rare event and only few publications have reported
simultaneous infection by two different types of influ-
enza viruses in humans [3-7]. Thus, the factors that may
be responsible for such events are not clear yet, even
though the host immune system and the virus proper-
ties have been suggested [3-7]. It is interesting to note
that both co-infected patients reported in this study
represented individuals with a weak immune system,
being a kidney transplant recipient and a 6 month year
old child, thus suggesting that, indeed, the immunologi-
cal state of the patient may play an important role in
the co-infection establishment. Moreover, the child
described in this study represents, to our knowledge, the
first report of a dual infected patient with a clinical
complication (pneumonia). Indeed, in all publications
clinical manifestations in co-infected individuals were
identical to those observed in single infections, with
classical symptoms, without any clinical complication.
However, it has to be mentioned that both these latter
observations may be related to the specific cohort (hos-
pitalized patients) taken into consideration in the cur-
rent study. Thus a clear correlation between dual-
infection and immunodeficiency/maturation, or dual
Table 1 Analysis performed for the identification of the
two double positive samples.
Nasal swab MDCK.2 inoculation
Patient # real time RT-PCR IFA real time RT-PCR
Type A Type B Type A Type B Type A Type B
1+ + + ++ +
2+ + + ++ +
Nasal swabs of the two co-infected patients were directly analyzed by real
time RT-PCR (Nasal swab) and inoculated in MDCK.2 cells (MDCK.2 inoculation)
in order to confirm the presence of both viruses (Type A and Type B) by IFA
and real time RT-PCR. “+” indicates a positive result.
Table 2 Kinetic of viral clearance in nasal swabs of
patient n° 1.
DAYS OF COLLECTION INFLUENZA
Type A Type B
11
th February positive
(Ct 31.92)
positive
(Ct 31.49)
15
th February positive
(Ct 38.40)
negative
18
th February negative negative
The table reports the results of the real time RT-PCR assays performed on
samples collected from patient number 1. Ct stands for real time cycle
threshold.
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concluded by these data. On the other hand, both
patients fully recovered. An oseltamivir based treatment
was adopted only in the case of the adult patient, justi-
fied by his immunodeficiency state more than by the
severity of the symptoms which remain mild till the
viral clearance.
Finally, in contrast with previous literature data [4], in
our two cases we did not observe significant differences
in the RNA levels of the two viruses in the initial sam-
ple, a part for a slight higher amount of influenza B
virus in the case of the child (roughly 10 times). How-
ever, in the case of the adult patients, for whom three
sequential samples were analysed (Table 2), we observed
a different kinetic in the viral clearance, with the influ-
enza B virus becoming undetectable more rapidly than
the influenza A virus. This finding may related to a dif-
ferent in vivo replication efficiency of two viruses. In
fact, influenza A infections are usually more severe than
those related to influenza B. However, further studies
would be needed to support this hypothesis.
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